CALGARY, Alberta and ZÜRICH, Switzerland – April 23, 2013 – Acceleware Ltd. (TSXV:AXE) today announced that SCANCO Medical AG, Zürich, Switzerland has agreed to acquire a perpetual, non-exclusive license for Acceleware’s AxRecon™ source code. AxRecon is an advanced GPU solution for accelerated image reconstruction on Computed Tomography (CT) scanners. Under the license acquisition terms, SCANCO will become the exclusive provider of AxRecon to the medical imaging market. SCANCO intends to continue advancing the product and expand its availability to a wider range of CT scanners.

“AxRecon is an innovative application that enables single and multiple GPU processing for accelerated image reconstruction on our high resolution scanners,” said Dr. Bruno Koller, Chief Executive Officer of SCANCO Medical AG. “This solution has been successfully employed for many years by select SCANCO customers and we look forward to evolving the solution and making it available to our entire customer base.”

“SCANCO is a natural home for the AxRecon solution to flourish. Their extensive industry expertise will further enable innovation of the product, benefitting existing and new customers,” said Robert Miller, Chief Marketing and Sales Officer of Acceleware. “This transaction is another step in Acceleware’s strategy to focus on our seismic imaging, electromagnetic solutions and consulting services for the Oil & Gas industry.”

Acceleware will retain all intellectual property rights to AxRecon and will continue to use the technology in its high performance computing consulting business for customers outside of the Medical Imaging market area.

About Acceleware:

Acceleware develops and markets high performance computing (HPC) software solutions for the engineering and energy industries. These solutions allow customers to speed-up simulation and data processing algorithms, benefitting from HPC technologies such as multi-core CPUs and massively parallel many-core GPUs. Acceleware software, specialized HPC training and consulting services are deployed by companies worldwide such as Boston Scientific, Samsung, LG, General Mills, Nokia, RIM, Medtronic, Hitachi, FDA, Mitsubishi, Sony Ericsson, Fugro, and Rock Solid Images to speed up product design, analyze data and make better business decisions.

Acceleware is a public company on Canada's TSX Venture Exchange under the trading symbol AXE.

About SCANCO Medical AG:

SCANCO Medical is a Swiss company that specializes in the development of state-of-the-art micro-computed tomography systems. These systems integrate high-quality imaging with powerful 3D analysis tools.
We provide long-term support to our customers that include technical assistance, maintenance, updates and training.

Leading academic, industrial and healthcare institutions worldwide employ SCANCO Medical microCT systems in a wide range of applications.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Accelerate your clean energy future: learn how RF XL can work for you.